长QT综合征的遗传检测:将致病突变与良性变异区分开来
Suraj Kapa1, David J Tester, Benjamin A Salisbury
1Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Circulation
|October 21, 2009
概括
长QT综合征 (LQTS) 的遗传检测依赖于识别致病突变. 突变类型和位置对于区分致病变体和罕见变体至关重要,特别是错误感应突变.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 长QT综合征 (LQTS) 的遗传检测对于诊断,预后和治疗至关重要.
- 已知12个LQTS敏感性基因中的数百个突变.
- 临床遗传测试通常集中在三个最常见的基因上.
研究的目的:
- 量化突变类型和基因/蛋白质区域对LQTS突变致病概率的影响.
- 在基因测试解释中区分致病突变和罕见变异.
主要方法:
- 对比388个确定的LQTS病例中的突变类型,频率和位置,与KCNQ1,KCNH2和SCN5A.的1300多个健康对照进行了比较.
- 根据类型和位置确定突变的估计预测值.
主要成果:
- 在LQTS病例中,突变的发生率是对照病例的10倍.
- 非误解突变的预测值>99%,无论位置如何.
- 误解突变的致病性因地点而异,一些地区的预测值为0%,另一些地区为100%.
结论:
- 准确解释LQTS基因测试需要区分致病突变与罕见变异.
- 在KCNQ1和KCNH2 (跨膜,链接器,孔隙) 内的特定突变位置可以自信地识别高概率的LQTS引起突变.
- 这些发现对分析其他遗传疾病的突变有更广泛的影响.
相关概念视频
Principles of Pharmacogenetics: Types of Genetic Variants
143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


